|4Dec 18, 7:11 PM ET

Decker Lisa Lynn 4

4 · IGM Biosciences, Inc. · Filed Dec 18, 2024

Insider Transaction Report

Form 4
Period: 2024-12-16
Decker Lisa Lynn
CHIEF BUSINESS OFFICER
Transactions
  • Sale

    Common Stock

    2024-12-16$7.48/sh1,063$7,95178,041 total
Footnotes (2)
  • [F1]These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.
  • [F2]This transaction was executed in multiple trades at prices ranging from $7.00 to $7.84. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer full information regarding the number of shares sold at each separate sale price.

Documents

1 file
  • 4
    form4-12192024_121248.xmlPrimary